Journal of Drug Targeting

Informa Healthcare

Bimonthly

Science Citation Index Expanded

13 days avg. from submission to first decision 43 days avg. from submission to first post-review decision 10 days avg. from acceptance to online publication

Journal of Drug Targeting is a subscription-based, peer-reviewed journal that publishes research on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs.

Papers are not restricted to drugs delivered by way of a carrier, but also include studies on molecular and macromolecular drugs that are designed to target specific cellular or extra-cellular molecules, as well as on the identification of novel drug targets. As such the journal publishes results on the activity, delivery and targeting of therapeutic peptides/proteins and nucleic acids including genes/plasmid DNA, RNA-based therapeutics (e.g. mRNA, microRNAs), gene-editing and gene silencing nucleic acids (e.g. small interfering (si)RNA, antisense oligonucleotides, ribozymes, DNAzymes), as well as small-molecule drugs, aptamers, mononucleotides and monoclonal antibodies and their conjugates. The diagnostic application of targeting technologies as well as targeted delivery of therapeutic, diagnostic and imaging agents also fall within the scope of the journal. In addition, papers are sought on self-regulating systems, systems responsive to their environment and to external stimuli and those that can produce programmed, pulsed and otherwise complex delivery patterns.

Journal of Drug Targeting also carries papers on the physiological and other biological barriers to delivery and targeting, and means of overcoming the barriers, for example, by penetration enhancers, and covers subjects such as extravasation, diffusion in tumours and target tissues, avoidance of the reticulo-endothelial system, and toxicity testing and licensing of novel delivery systems.

The journal’s audience includes, but is not limited to, scientists working in the pharmaceutical and biopharmaceutical sciences, drug delivery and targeting, molecular and biological sciences, pharmacology, toxicology, chemistry, and materials/polymer sciences.

Journal of Drug Targeting welcomes for consideration the following types of article: original articles, reviews, article commentaries, book reviews, letters, communications, and method articles. All articles received by the Journal will be subject to single-anonymous peer review.